NHMRC Australia-China Exchange Fellowship: Improving the bioavailability of peptide-based therapeutics for the treatment of Multiple Sclerosis (2012–2013)

Abstract:
Many diseases are controlled at the molecular level by proteins and their interactions with other proteins. Harmonin is a key protein in Usher syndrome, the most common form of deaf-blindness in humans, and harmonin has similarities to some proteins involved in Alzheimer¿s disease. We seek to understand how harmonin works. The findings of this study may lead to new treatments for deaf-blindness and Alzheimer¿s disease.
Grant type:
NHMRC Training (Postdoctoral) Fellowship
Researchers:
  • Senior Research Officer
    Institute for Molecular Bioscience
Funded by:
National Health and Medical Research Council